208 related articles for article (PubMed ID: 15178516)
21. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
Sacks FM
Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
[No Abstract] [Full Text] [Related]
22. Goodbye avandia!
Alzaid AA
Saudi Med J; 2010 Dec; 31(12):1301-2. PubMed ID: 21135990
[No Abstract] [Full Text] [Related]
23. Diabetes field cautiously upbeat despite possible setback for leading SGLT2 inhibitor.
Jones D
Nat Rev Drug Discov; 2011 Aug; 10(9):645-6. PubMed ID: 21878967
[No Abstract] [Full Text] [Related]
24. Reversing the tide of metabolic syndrome.
Dumas MA
Nurs Manage; 2003 Jun; 34 Suppl Guide():1-5. PubMed ID: 12867772
[TBL] [Abstract][Full Text] [Related]
25. The metabolic syndrome: a gathering challenge in a time of abundance.
Bricker LA; Greydanus DE
Adolesc Med State Art Rev; 2008 Dec; 19(3):475-97, ix. PubMed ID: 19227387
[TBL] [Abstract][Full Text] [Related]
26. Risk reduction therapy for syndrome X: comparison of several treatments.
Oron-Herman M; Sela BA; Rosenthal T
Am J Hypertens; 2005 Mar; 18(3):372-8. PubMed ID: 15797656
[TBL] [Abstract][Full Text] [Related]
27. [Potential of combined hypoglycemic, antihypertensive, and hypolipidemic therapy in patients with diabetes mellitus and diabetic foot syndrome].
Onuchin SG; Elsukova OS; Onuchina EL
Klin Med (Mosk); 2008; 86(8):61-6. PubMed ID: 18819351
[TBL] [Abstract][Full Text] [Related]
28. Drug companies accused of stalling tailored therapies.
Sinha G
Nat Med; 2006 Sep; 12(9):983. PubMed ID: 16960561
[No Abstract] [Full Text] [Related]
29. The UGDP and the FDA audit.
Am Fam Physician; 1979 Jul; 20(1):67. PubMed ID: 377929
[No Abstract] [Full Text] [Related]
30. [Practical management of oral antidiabetics in patients with renal disease].
Alcazar R; Gonzalez Albarran O; Honorato J; Robles NR; Acha J; de Alvaro F; Fernandez Gallego V; Gomez Garcia P; Lopez de la Torre M; Martinez Castelao A; Romero R
Nefrologia; 2006; 26(5):538-58. PubMed ID: 17117897
[No Abstract] [Full Text] [Related]
31. New horizons in diabetes treatment.
Marino MT
Diabetes Self Manag; 2003; 20(5):67-8, 70. PubMed ID: 14679954
[No Abstract] [Full Text] [Related]
32. Management of the metabolic syndrome-nicotinic acid.
Meyers CD; Kashyap ML
Endocrinol Metab Clin North Am; 2004 Sep; 33(3):557-75, vii. PubMed ID: 15262297
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the safety of diabetes drugs: perspective of a Food and Drug Administration insider.
Misbin RI
Diabetes Care; 2005 Oct; 28(10):2573-6. PubMed ID: 16186303
[No Abstract] [Full Text] [Related]
34. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
Jones PH
Am J Cardiol; 2008 Dec; 102(12A):41L-47L. PubMed ID: 19084089
[TBL] [Abstract][Full Text] [Related]
35. New diabetes insurance laws present challenges for states.
J Am Diet Assoc; 1998 May; 98(5):514. PubMed ID: 9597020
[No Abstract] [Full Text] [Related]
36. 4-Hydroxyisoleucine: a plant-derived treatment for metabolic syndrome.
Jetté L; Harvey L; Eugeni K; Levens N
Curr Opin Investig Drugs; 2009 Apr; 10(4):353-8. PubMed ID: 19337956
[TBL] [Abstract][Full Text] [Related]
37. Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer.
Berstein LM
Cancer Lett; 2005 Jun; 224(2):203-12. PubMed ID: 15914271
[TBL] [Abstract][Full Text] [Related]
38. [The effect of glitazones on the progression of type 2 diabetes and on cardiovascular endpoints].
Schatz H
Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1825-30. PubMed ID: 16052448
[No Abstract] [Full Text] [Related]
39. New approaches in the intensive management of cardiovascular risk in the metabolic syndrome.
Rosenson RS
Curr Probl Cardiol; 2005 May; 30(5):241-79. PubMed ID: 15829899
[TBL] [Abstract][Full Text] [Related]
40. Oral antidiabetics: philosophy and politics.
Bowen AJ
J Med Assoc Ga; 1976 Nov; 65(11):411-4. PubMed ID: 993676
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
